Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINOF Study
2010-023871-25Phase 4Completed
- Sponsor
- Nottingham University Hospitals
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levobupivacaine and ropivacaine in hip fracture and postoperative pain (2 arms), sponsored by Nottingham University Hospitals. Primary endpoints: Cumulative ambulation score and Cumulative dynamic pain score. Started Feb 2011; status: completed.
02
Drugs
levobupivacaineropivacaine
03
Conditions
hip fracturepostoperative pain
Beyond the preview
Go deeper on 2010-023871-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023871-25.